Payment overview · 2025
General Payments
$26.77
2 reported records · 2 companies
Healthcare provider profile · identity verified
Peter Michael Manis, M. D.
Allopathic & Osteopathic Physicians|Emergency Medicine · PENSACOLA, FL · NPI 1164485926
Verified facts
What the public records show
CMS Open Payments records show Peter Michael Manis, M. D. received $26.77 in general payments during 2025 across 2 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 80.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $21.63 | 80.8% | 1 | 2025 |
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $5.14 | 19.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $26.77 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $21.63 | 1 | 2025 |
Source payment records
|
|||||
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $5.14 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 574 | 79 |
| Eliquis | Apixaban | 574 | 40 |
| Furosemide | Furosemide | 365 | 58 |
| Amlodipine Besylate | Amlodipine Besylate | 360 | 61 |
| Gabapentin | Gabapentin | 304 | 52 |
| Potassium Chloride | Potassium Chloride | 302 | 58 |
| Metoprolol Tartrate | Metoprolol Tartrate | 298 | 41 |
| Levothyroxine Sodium | Levothyroxine Sodium | 248 | 38 |
| Trazodone Hcl | Trazodone Hcl | 200 | 29 |
| Trulicity | Dulaglutide | 190 | 15 |
| Levetiracetam | Levetiracetam | 188 | 20 |
| Losartan Potassium | Losartan Potassium | 188 | 31 |
| Duloxetine Hcl | Duloxetine Hcl | 187 | 21 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 186 | 45 |
| Lisinopril | Lisinopril | 180 | 31 |
| Sertraline Hcl | Sertraline Hcl | 172 | 25 |
| Tamsulosin Hcl | Tamsulosin Hcl | 171 | 30 |
| Carvedilol | Carvedilol | 164 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 148 | 25 |
| Ondansetron Hcl | Ondansetron Hcl | 139 | 33 |
| Famotidine | Famotidine | 135 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 125 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 119 | 22 |
| Metformin Hcl | Metformin Hcl | 116 | 25 |
| Mirtazapine | Mirtazapine | 116 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 113 | 20 |
| Cephalexin | Cephalexin | 112 | 52 |
| Divalproex Sodium | Divalproex Sodium | 112 | 19 |
| Pantoprazole Sodium | Pantoprazole Sodium | 108 | 22 |
| Omeprazole | Omeprazole | 106 | 23 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 103 | 14 |
| Baclofen | Baclofen | 100 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 98 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 96 | 22 |
| Donepezil Hcl | Donepezil Hcl | 91 | 14 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 91 | suppressed |
| Alprazolam | Alprazolam | 84 | 19 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 84 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 82 | 16 |
| Sodium Chloride | 0.9 % Sodium Chloride | 82 | 30 |
| Tramadol Hcl | Tramadol Hcl | 81 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 80 | 12 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 80 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 79 | 32 |
| Memantine Hcl | Memantine Hcl | 75 | 12 |
| Xarelto | Rivaroxaban | 75 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 73 | 11 |
| Bumetanide | Bumetanide | 72 | 11 |
| Lactulose | Lactulose | 72 | 13 |
| Olanzapine | Olanzapine | 71 | 11 |
| Prednisone | Prednisone | 71 | 18 |
| Allopurinol | Allopurinol | 69 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 65 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 64 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 64 | 13 |
| Nystatin | Nystatin | 62 | 26 |
| Finasteride | Finasteride | 59 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 54 | 13 |
| Bupropion Xl | Bupropion Hcl | 54 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 53 | suppressed |
| Levemir Flexpen | Insulin Detemir | 51 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 50 | 22 |
| Clonidine Hcl | Clonidine Hcl | 50 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 49 | 20 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 49 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 49 | suppressed |
| Simvastatin | Simvastatin | 49 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 47 | 21 |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 47 | 19 |
| Linzess | Linaclotide | 47 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 46 | 22 |
| Latanoprost | Latanoprost | 46 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 45 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 44 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 44 | suppressed |
| Risperidone | Risperidone | 44 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 39 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 39 | 14 |
| Meloxicam | Meloxicam | 38 | suppressed |
| Lorazepam | Lorazepam | 37 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 36 | 12 |
| Myrbetriq | Mirabegron | 36 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 35 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Ezetimibe | Ezetimibe | 33 | suppressed |
| Lacosamide | Lacosamide | 33 | suppressed |
| Novolog Flexpen | Insulin Aspart | 33 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 33 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 33 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 32 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 32 | suppressed |
| Ertapenem | Ertapenem Sodium | 32 | 16 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 31 | 30 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 31 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 30 | suppressed |
| Spironolactone | Spironolactone | 29 | 11 |
| Pregabalin | Pregabalin | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Sucralfate | Sucralfate | 26 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 25 | suppressed |
| Azithromycin | Azithromycin | 25 | 17 |
| Atenolol | Atenolol | 24 | suppressed |
| Clonazepam | Clonazepam | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Amantadine | Amantadine Hcl | 23 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 23 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | suppressed |
| Vraylar | Cariprazine Hcl | 23 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 22 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 22 | suppressed |
| Metronidazole | Metronidazole | 22 | 11 |
| Tradjenta | Linagliptin | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Cefazolin Sodium-Dextrose | Cefazolin Sodium/Dextrose,iso | 21 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 21 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | 11 |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 20 | suppressed |
| Clonidine | Clonidine | 19 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 19 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 18 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 18 | 15 |
| Oxycontin | Oxycodone Hcl | 18 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Acetylcysteine | Acetylcysteine | 16 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 16 | 14 |
| Gemtesa | Vibegron | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Rivastigmine | Rivastigmine | 15 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 15 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 14 | 13 |
| Calcium Acetate | Calcium Acetate | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | 11 |
| Levemir | Insulin Detemir | 13 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 13 | suppressed |
| Entacapone | Entacapone | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 12 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $26.77 · 2 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, Zunveyl | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error